Cargando…
6‐Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
BACKGROUND AND PURPOSE: l‐DOPA‐induced dyskinesia (LID) is considered a major complication in the treatment of Parkinson's disease (PD). Buspirone (5‐HT(1A) partial agonist) have shown promising results in the treatment of PD and LID, however no 5‐HT‐based treatment has been approved in PD. The...
Autores principales: | Vegas‐Suárez, Sergio, Pisanò, Clarissa Anna, Requejo, Catalina, Bengoetxea, Harkaitz, Lafuente, Jose Vicente, Morari, Michele, Miguelez, Cristina, Ugedo, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429490/ https://www.ncbi.nlm.nih.gov/pubmed/32464686 http://dx.doi.org/10.1111/bph.15145 |
Ejemplares similares
-
The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
por: Vegas‐Suárez, Sergio, et al.
Publicado: (2021) -
Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation
por: Vegas-Suárez, Sergio, et al.
Publicado: (2022) -
Mesencephalic origin of the rostral Substantia nigra pars reticulata
por: Madrigal, M. Pilar, et al.
Publicado: (2015) -
Activity of the Substantia Nigra Pars Reticulata during Saccade Adaptation
por: Kojima, Yoshiko, et al.
Publicado: (2023) -
Intraoperative Microelectrode Recordings in Substantia Nigra Pars Reticulata in Anesthetized Rats
por: Li, Hanyan, et al.
Publicado: (2020)